Michael Andrew Chambers, Director at Sarepta Therapeutics, Inc. (SRPT), bought 46,170 shares at $108.80 ($5.0M) on 2022-08-19, disclosed to the SEC on 2022-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.20 | 40,110 | $4.3M | 86.8% |
| 2 | $108.80 | 6,060 | $659K | 13.2% |
| Total | $108.28 avg | 46,170 | $5.0M | 100% |
| Filing → |
| SRPT | BUY | 2023-08-14 | $5.1M | — | Filing → |
| SRPT | BUY | 2023-08-11 | $7.4M | — | Filing → |
| SRPT | BUY | 2022-09-15 | $11.3M | — | Filing → |